MYO5B and microvillus inclusion disease: These findings suggest that the trafficking and differentiation blockades induced by MYO5B inactivation can be overcome by LPA-activated pathways, leading to the possible development of drug treatments for MVID that could obviate the need for multiorgan transplantation or long-term total parenteral nutrition.